The Effect of Probiotics and Synbiotics on Risk Factors Associated with Cardiometabolic Diseases in Healthy People-A Systematic Review and Meta-Analysis with Meta-Regression of Randomized Controlled Trials

Journal of Clinical Medicine
Karolina Skonieczna-ŻydeckaIgor Łoniewski

Abstract

We aimed to systematically review the effectiveness of probiotic/synbiotic formulations to counteract cardiometabolic risk (CMR) in healthy people not receiving adjunctive medication. The systematic search (PubMed/MEDLINE/Embase) until 1 August 2019 was performed for randomized controlled trials in >20 adult patients. Random-effect meta-analysis subgroup and meta-regression analysis of co-primary (haemoglobin A1c (HbA1C), glucose, insulin, body weight, waist circumference (WC), body mass index (BMI), cholesterol, low-density lipoproteins (LDL), high-density lipoproteins (HDL), triglycerides, and blood pressure) and secondary outcomes (uric acid, plasminogen activator inhibitor-1-PAI-1, fibrinogen, and any variable related to inflammation/endothelial dysfunction). We included 61 trials (5422 persons). The mean time of probiotic administration was 67.01 ± 38.72 days. Most of probiotic strains were of Lactobacillus and Bifidobacterium genera. The other strains were Streptococci, Enterococci, and Pediococci. The daily probiotic dose varied between 106 and 1010 colony-forming units (CFU)/gram. Probiotics/synbiotics counteracted CMR factors (endpoint data on BMI: standardized mean difference (SMD) = -0.156, p = 0.006 and difference i...Continue Reading

References

Nov 1, 1989·Journal of Dairy Science·S Y LinW E Sandine
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Apr 4, 2000·European Journal of Clinical Nutrition·L Agerholm-LarsenA Astrup
Nov 27, 2002·The American Journal of Clinical Nutrition·Marek NaruszewiczHanna Bukowska
Jul 4, 2006·Annals of Nutrition & Metabolism·Elisabeth Fabian, Ibrahim Elmadfa
Nov 28, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Leon A SimonsPatricia Conway
Mar 16, 2007·European Journal of Clinical Nutrition·K A GreanyM S Kurzer
Apr 26, 2007·Diabetes·Patrice D CaniRémy Burcelin
Jan 27, 2010·The British Journal of Nutrition·Haleh Sadrzadeh-YeganehMaryam Chamary
Jun 24, 2011·European Journal of Clinical Nutrition·B J ChangD K Chang
Jul 26, 2011·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Oct 25, 2011·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Ulrike TrautvetterGerhard Jahreis
Mar 2, 2012·International Journal of Sports Medicine·I A VälimäkiT Vasankari
May 31, 2012·International Journal of Sport Nutrition and Exercise Metabolism·Michael GleesonClaire Lawrence
Oct 6, 2012·Annals of Nutrition & Metabolism·Miriam Bermudez-BritoAngel Gil
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amandine EverardPatrice D Cani
Aug 31, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·K L IveyR L Prince
Sep 10, 2014·Best Practice & Research. Clinical Gastroenterology·Emily J Dhurandhar, Scott W Keith
Nov 19, 2014·Molecular Nutrition & Food Research·Nestor IshimweGuocheng Du
Dec 3, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Luzia ValentiniHerbert Lochs
Jun 19, 2015·Clinical and Translational Gastroenterology·Parth J ParekhDavid A Johnson

❮ Previous
Next ❯

Citations

Dec 10, 2020·Clinical and Translational Allergy·Jean BousquetUNKNOWN ARIA group
May 1, 2021·Pharmaceuticals·Oliwia Gawlik-Kotelnicka, Dominik Strzelecki

❮ Previous
Next ❯

Software Mentioned

Comprehensive Meta - Analysis
WebPlotDigitizer

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.